Causes, Frequencies, and Predictors of Relapse in Patients with Ulcerative Colitis on Long-Term Follow-Up in a Tertiary Care Hospital of Northern India

被引:0
作者
Jain, Rahul [1 ]
Singh, Vani [2 ]
Naik, A. K. [3 ]
Singh, Santosh Kumar [4 ]
Chakrabarty, Barun Kumar [5 ]
Ranjan, Priya [6 ]
Kumar, Premshankar [7 ]
机构
[1] Command Hosp NC, Dept Med & Gasteroenterol, Udampur, Jammu & Kashmir, India
[2] ECHS Polyclin, Udampur, Jammu & Kashmir, India
[3] AFMC, Dept Hosp Adm, Pune, Maharashtra, India
[4] AFMC, Dept Med, Pune, Maharashtra, India
[5] 151 Base Hosp, Dept Pathol, Gauhati, Assam, India
[6] Command Hosp NC, Dept Gatrointestinal Surg, Udampur, Jammu & Kashmir, India
[7] Command Hosp Eastern Command, Dept ENT, Kolkata, W Bengal, India
关键词
Predictors; relapse; remission; ulcerative colitis; DISEASE; PARAMETERS; MANAGEMENT; DIAGNOSIS; RISK;
D O I
10.4103/jmms.jmms_182_20
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Context: Ulcerative colitis (UC) initially thought to be a disease of developed world is equally common in India. Surprisingly, there are very scant data from India. The study was undertaken to find the frequency of relapse and to determine factors predictor of relapse in Indian population. Subjects and Methods: This study was conducted at a tertiary care center of New Delhi for a period of 1 year. Patients were included if they had a diagnosis of UC based on accepted historical, endoscopic, histological, and/or radiologic criteria. Detailed past/present history, baseline clinical examination, dietary details, and psychological analysis using shortened Depression Anxiety Stress Scale score, biochemical tests, inflammatory markers, endoscopic, and histopathological analysis were done at baseline and regular intervals. The outcome was clinical relapse or continued remission. Results: Out of 86 patients screened, 50 patients were included in the study according to inclusion criteria and were followed up. The frequency of relapse was 32%. Univariate analysis showed higher relapse frequency, frequency of steroid received in past, patients on immunomodulator therapy, presence of acute or chronic inflammatory cells on histology, and disease activity at baseline as predictors of relapse. There was no significant difference between anxiety, stress, and depression relapsers and those who maintained remission. On multivariate analysis, disease activity at baseline was the only independent predictor of relapse. Conclusions: Stringent control of disease activity with mucosal healing should be the aim, as mucosal healing is the only predictor for prolonged remission.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 26 条
  • [1] Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis A Cohort Study
    Ananthakrishnan, Ashwin N.
    Higuchi, Leslie M.
    Huang, Edward S.
    Khalili, Hamed
    Richter, James M.
    Fuchs, Charles S.
    Chan, Andrew T.
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 156 (05) : 350 - U170
  • [2] Biological and Histological Parameters as Predictors of Relapse in Ulcerative Colitis: A Prospective Study
    Azad, Sheenam
    Sood, Neena
    Sood, Ajit
    [J]. SAUDI JOURNAL OF GASTROENTEROLOGY, 2011, 17 (03) : 194 - 198
  • [3] World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
    Bernstein, Charles N.
    Fried, Michael
    Krabshuis, J. H.
    Cohen, Henry
    Eliakim, R.
    Fedail, Suleiman
    Gearry, Richard
    Goh, K. L.
    Hamid, Saheed
    Khan, Aamir Ghafor
    LeMair, A. W.
    Prof Malfertheiner
    Qin Ouyang
    Rey, J. F.
    Sood, Ajit
    Steinwurz, Flavio
    Thomsen, Ole O.
    Thomson, Alan
    Watermeyer, Gillian
    [J]. INFLAMMATORY BOWEL DISEASES, 2010, 16 (01) : 112 - 124
  • [4] Self-reported treatment adherence in inflammatory bowel disease in Indian patients
    Bhatt J.
    Patil S.
    Joshi A.
    Abraham P.
    Desai D.
    [J]. Indian Journal of Gastroenterology, 2009, 28 (4) : 143 - 146
  • [5] Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
    Bitton, A
    Peppercorn, MA
    Antonioli, DA
    Niles, JL
    Shah, S
    Bousvaros, A
    Ransil, B
    Wild, G
    Cohen, A
    Edwardes, MDD
    Stevens, AC
    [J]. GASTROENTEROLOGY, 2001, 120 (01) : 13 - 20
  • [6] Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study
    Burisch, Johan
    Katsanos, Konstantinos H.
    Christodoulou, Dimitrios K.
    Barros, Luisa
    Magro, Fernando
    Pedersen, Natalia
    Kjeldsen, Jens
    Vegh, Zsuzsanna
    Lakatos, Peter L.
    Eriksson, Carl
    Halfvarson, Jonas
    Fumery, Mathurin
    Gower-Rousseau, Corinne
    Brinar, Marko
    Cukovic-Cavka, Silvija
    Nikulina, Inna
    Belousova, Elena
    Myers, Sally
    Sebastian, Shaji
    Kiudelis, Gediminas
    Kupcinskas, Limas
    Schwartz, Doron
    Odes, Selwyn
    Kaimakliotis, Ioannis P.
    Valpiani, Daniela
    D'Inca, Renata
    Salupere, Riina
    Zammit, Stefania Chetcuti
    Ellul, Pierre
    Duricova, Dana
    Bortlik, Martin
    Goldis, Adrian
    Kievit, Hendrika Adriana Linda
    Toca, Alina
    Turcan, Svetlana
    Midjord, Jongero
    Nielsen, Kari Rubek
    Andersen, Karina Winther
    Andersen, Vibeke
    Misra, Ravi
    Arebi, Naila
    Oksanen, Pia
    Collin, Pekka
    de Castro, Luisa
    Hernandez, Vicent
    Langholz, Ebbe
    Munkholm, Pia
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (02) : 198 - 208
  • [7] Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure
    Chateau, Thomas
    Feakins, Roger
    Marchal-Bressenot, Aude
    Magro, Fernando
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (02) : 179 - 189
  • [8] Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission
    Cushing, Kelly C.
    Tan, William
    Alpers, David H.
    Deshpande, Vikram
    Ananthakrishnan, Ashwin N.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (03) : 347 - 355
  • [9] Do Non-steroidal Anti-inflammatory Drugs Cause Exacerbations of Inflammatory Bowel Disease?
    Feagins, Linda A.
    Cryer, Byron L.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (02) : 226 - 232
  • [10] Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis
    Frin, Anne-Claire
    Filippi, Jerome
    Boschetti, Gilles
    Flourie, Bernard
    Drai, Jocelyne
    Ferrari, Patricia
    Hebuterne, Xavier
    Nancey, Stephane
    [J]. DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : 11 - 16